14 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
knowingly and willfully soliciting, offering, receiving, or providing any remuneration (including any kickback, bribe, or certain rebate), directly
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
soliciting, offering, receiving, or providing any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly
S-1/A
EX-1.1
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
knowingly and willfully soliciting, offering, receiving, or providing any remuneration (including any kickback, bribe, or certain rebate), directly
S-1
ep1oz6
25 Aug 23
IPO registration
5:03pm
DRS/A
3pw1tv49fo tw8pbqmn
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
6sox4 snpjzteb9mbbsc
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
uoi4yf0yjlt0rdb5r
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
h0mg0ingj2kox1 ky
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
m9eswt6nzfoxawtmvxx
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
ud6advmibdkgf9ja
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
6jxwfz
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
sxmi lm05qstml
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next